Skip to content
2000
Volume 19, Issue 27
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Elevated serum uric acid (SUA) levels (i.e. hyperuricaemia) have been associated with metabolic syndrome (MetS) and cardiovascular disease (CVD) morbidity and mortality. Elevated SUA levels predict the onset of type 2 diabetes (T2DM). SUA levels are increased during the early stages of impaired glucose metabolism. Furthermore, in diabetic patients, hyperuricaemia has been linked to both micro- and macrovascular complications. The present review considers: (1) SUA levels in patients with MetS, type 1 diabetes and T2DM; (2) the mechanisms that influence SUA levels in these patients; (3) the potential links between SUA and diabetic complications. The effect on SUA levels of drugs commonly prescribed for T2DM and the risk of uric acid nephrolithiasis in patients with MetS or DM are also briefly discussed.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612811319270016
2013-08-01
2025-05-13
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612811319270016
Loading

  • Article Type:
    Research Article
Keyword(s): diabetic complications; drugs; type 1 diabetes; type 2 diabetes; Uric acid
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test